UNSPSC 51101635: Arsthinol

This classification denotes an antiprotozoal agent with the molecular formula C11H14AsNO3S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QNT09A162Y, chemically known as 2-hydroxy-5-(4-hydroxymethyl-1,3,2-dithiarsolan-2-yl)acetanilid but generally known as arsthinol, which bears US NIH Compound Identifier 8414. European Medicines Agency schedules Arsthinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05572MIG. The term ARSTHINOL is an International Non-Proprietary Name.

UNSPSC 51101635 Arsthinol, a Commodity code, covers pharmaceutical products and medical supplies that state and local governments procure for health and emergency response operations. Recent solicitations show state and local buyers sourcing naloxone (opioid-overdose reversal medication), safe drug deactivation systems, medical and first aid supplies for fire-rescue operations, and generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing arrangements. The issuing bodies span county health departments, municipal fire departments, state health and human services agencies, and multistate cooperative purchasing alliances. Work under this code includes competitive sealed bidding for emergency medical supplies with specific line-item quantities and delivery schedules, requests for information to evaluate direct-to-manufacturer prescription programs, and regional or statewide RFPs establishing framework contracts with multiple manufacturers and authorized wholesalers.

Activity is geographically dispersed across Florida, Texas, Minnesota, and Oregon. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's Bid 26-P-00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000.00 and sheltered for certified Small Local Business Enterprises with a 5 percent SLBE bid discount; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) seeking vendor capabilities for a Direct-to-Manufacturer Prescriptions program; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) establishing contracts for generic pharmaceuticals and OTC products across participating state and local facilities in multiple states. Cooperative purchasing and multistate frameworks appear to be a growing vehicle for larger pharmaceutical and supply procurements, while individual jurisdictions continue to issue direct solicitations for emergency medical supplies with firm delivery and quality-assurance requirements.